Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Regulatory News (REL)

Share Price Information for Relx (REL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,329.00
Bid: 3,327.00
Ask: 3,328.00
Change: 48.00 (1.46%)
Spread: 1.00 (0.03%)
Open: 3,303.00
High: 3,331.00
Low: 3,291.00
Prev. Close: 3,281.00
REL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

22 Feb 2024 13:07

RNS Number : 1499E
RELX PLC
22 February 2024
 

22 February 2024 

RELX PLC

Publication of 2023 Annual Report including Financial Statements and Corporate Responsibility Report and Annual Report on Form 20-F

 

RELX PLC (the "Company") has today published the following documents on its website at www.relx.com:

 

- Annual Report including Financial Statements and Corporate Responsibility Report for the year ended 31 December 2023 (the "2023 Annual Report");

 

- Annual Report on Form 20-F for the year ended 31 December 2023 ("2023 Form 20-F")

 

- 2023 Annual Report with Netherlands specific audit opinion (the "2023 NL Annual Report"); and

 

The 2023 Annual Report will be submitted to the National Storage Mechanism today and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The 2023 Form 20-F will be filed with the US Securities and Exchange Commission ("SEC") today and will be available on the SEC's website at www.sec.gov.

 

The 2023 NL Annual Report has been published in accordance with the European Single Electronic Format requirements as in force in the European Union and applicable to RELX by virtue of its listing on Euronext Amsterdam and will be submitted to the Dutch Authority for the Financial Markets (AFM). The AFM publishes the report in its public register.

 

The total number of voting rights in RELX PLC's issued share capital (exclusive of shares held in treasury) is currently 1,883,186,240.

 

Directors' Responsibility Statement

Additional information required to be made available by the Company under Rule 6.3.5 of the Disclosure and Transparency Rules of the UK Financial Conduct Authority, to the extent not already included in the RELX 2023 Results Announcement issued on 15 February 2024, is set out below.

 

The following responsibility statement is extracted from page 155 of the 2023 Annual Report and is repeated here solely for the purposes of complying with Disclosure and Transparency Rule 6.3.5. Responsibility is for the full 2023 Annual Report, not the information presented in this announcement or the RELX 2023 Results Announcement.

 

Each of the Directors, whose names and roles can be found on pages 108 and 109 of the 2023 Annual Report, confirms that, to the best of their knowledge:

- the consolidated financial statements, prepared in accordance with UK-adopted IAS in conformity with the requirements of the Companies Act 2006 and International Financial Reporting Standards (IFRS), give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group;

 

- the individual Company financial statements, prepared in accordance with Financial Reporting Standard 101 'Reduced Disclosure Framework' (FRS 101), gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company;

 

- the Strategic report includes a fair review of the development and performance of the business and the position of the Group, together with a description of the principal and emerging risks and uncertainties that it faces; and

 

- the Annual Report and Financial Statements, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's position and performance, business model and strategy.

 

Forward-looking statements

The 2023 Annual Report and the 2023 Form 20-F contain forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results or outcomes of RELX PLC (together with its subsidiaries, "RELX", "we" or "our") to differ materially from those expressed in any forward-looking statement. We consider any statements that are not historical facts to be "forward-looking statements". The terms "outlook", "estimate", "forecast", "project", "plan", "intend", "expect", "should", "could", "will", "believe", "trends" and similar expressions may indicate a forward-looking statement. Important factors that could cause actual results or outcomes to differ materially from estimates or forecasts contained in the forward-looking statements include, among others: regulatory and other changes regarding the collection or use of personal data; changes in law and legal interpretations affecting RELX intellectual property rights and internet communications; current and future geopolitical, economic and market conditions; changes in the payment model for RELX scientific, technical and medical research products; competitive factors in the

industries in which RELX operates and demand for RELX products and services; inability to realise the future anticipated benefits of acquisitions; compromises of RELX cyber security systems or other unauthorised access to our databases; changes in economic cycles, communicable disease epidemics or pandemics, severe weather events, natural disasters and terrorism; failure of third parties to whom RELX has outsourced business activities; significant failure or interruption of RELX systems; inability to retain high-quality employees and management; changes in tax laws and uncertainty in their application; exchange rate fluctuations; adverse market conditions or downgrades to the credit ratings of our debt; changes in the market values of defined benefit pension scheme assets and in the market-related assumptions used to value scheme liabilities; breaches of generally accepted ethical business standards or applicable laws; and other risks referenced from time to time in the filings of RELX PLC with the US Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date of the 2023 Annual Report and the 2023 Form 20-F. Except as may be required by law, we undertake no obligation to publicly update or release any revisions to these forward-looking statements, which speak only as of the date of the 2023 Annual Report and the 2023 Form 20-F, or to reflect events or circumstances after the date of the 2023 Annual Report and the 2023 Form 20-F, or to reflect the occurrence of unanticipated events.

 

- ENDS -

Enquiries

Paul Abrahams (Media)Tel: +44 20 7166 5724

paul.abrahams@relx.com

 

Colin Tennant (Investors)

Tel: +44 20 7166 5751

colin.tennant@relx.com

 

Notes for Editors

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. RELX serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 36,000 people, of whom over 40% are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £65bn, ?76bn, $82bn.

 

*Note: Current market capitalisation can be found at http://www.relx.com/investorcentre

 

 

RELX PLC

1-3 Strand

London WC2N 5JR

United Kingdom

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSUURORSNUUUAR
Date   Source Headline
26th Apr 20245:47 pmRNSTransaction in Own Shares
25th Apr 20246:01 pmRNSDirector/PDMR Shareholding
25th Apr 20245:13 pmRNSTransaction in Own Shares
25th Apr 20243:21 pmRNSResult of AGM
24th Apr 20245:17 pmRNSTransaction in Own Shares
23rd Apr 20245:42 pmRNSTransaction in Own Shares
22nd Apr 20245:25 pmRNSTransaction in Own Shares
19th Apr 20245:51 pmRNSTransaction in Own Shares
18th Apr 20245:29 pmRNSTransaction in Own Shares
17th Apr 20245:37 pmRNSTransaction in Own Shares
16th Apr 20245:30 pmRNSTransaction in Own Shares
15th Apr 20245:33 pmRNSTransaction in Own Shares
12th Apr 20245:32 pmRNSTransaction in Own Shares
11th Apr 20246:02 pmRNSTransaction in Own Shares
11th Apr 20242:04 pmRNSAdditional Listing
10th Apr 20245:14 pmRNSTransaction in Own Shares
9th Apr 20245:26 pmRNSTransaction in Own Shares
8th Apr 20245:31 pmRNSTransaction in Own Shares
4th Apr 20245:59 pmRNSTransaction in Own Shares
4th Apr 20242:00 pmRNSAdditional Listing
3rd Apr 20246:06 pmRNSTransaction in Own Shares
2nd Apr 20245:57 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTotal Voting Rights
28th Mar 20245:18 pmRNSTransaction in Own Shares
27th Mar 20245:56 pmRNSTransaction in Own Shares
26th Mar 20245:31 pmRNSTransaction in Own Shares
25th Mar 20245:24 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
21st Mar 20245:13 pmRNSTransaction in Own Shares
20th Mar 20245:09 pmRNSTransaction in Own Shares
19th Mar 20245:42 pmRNSTransaction in Own Shares
18th Mar 20245:14 pmRNSTransaction in Own Shares
15th Mar 20245:26 pmRNSTransaction in Own Shares
14th Mar 20245:21 pmRNSTransaction in Own Shares
13th Mar 20246:07 pmRNSTransaction in Own Shares
12th Mar 20245:49 pmRNSTransaction in Own Shares
11th Mar 20245:36 pmRNSTransaction in Own Shares
8th Mar 20246:14 pmRNSTransaction in Own Shares
8th Mar 20244:50 pmRNSNotice of AGM
7th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 20245:53 pmRNSTransaction in Own Shares
6th Mar 202410:45 amRNSAdditional Listing
5th Mar 20245:25 pmRNSTransaction in Own Shares
4th Mar 20245:20 pmRNSTransaction in Own Shares
1st Mar 20245:28 pmRNSTransaction in Own Shares
1st Mar 20245:24 pmRNSTotal Voting Rights
29th Feb 20245:08 pmRNSTransaction in Own Shares
28th Feb 20245:41 pmRNSTransaction in Own Shares
27th Feb 20245:19 pmRNSTransaction in Own Shares
26th Feb 20245:41 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.